Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling ...

Safety profiles were similar between formulations, with common adverse effects including fatigue, musculoskeletal pain, pruritus, rash, and cough. Dr. Eric K. Singhi discusses the significance of the ...

Discover how a common rash could be a sign of rosacea, a chronic condition affecting millions, and what new treatments can ...

P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Mind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...

Race and appointment availability are significant predictors for the continuity of care among patients with chronic inflammatory skin disease.

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Nemolizumab monotherapy may be an effective treatment for reducing pruritus and disease severity in adults with moderate to severe prurigo nodularis.